John Imeson
- Internal Medicine top 1%
- Hematology top 1%
- Neurology top 1%
- Neuroblastoma Research and Treatments 11
-
- Blood properties and coagulation 5
- Renal cell carcinoma treatment 4
-
- Renal and related cancers 7
-
- Childhood Cancer Survivors' Quality of Life 6
-
- Acute Lymphoblastic Leukemia research 6
-
- Lymphoma Diagnosis and Treatment 6
-
- Glioma Diagnosis and Treatment 5
- Co-authors
- Yvonne StirlingAndy HainesT W MeadeSimon G. ThompsonGeorge J. MillerRanjan ChakrabartiW. R. S. NorthM Brozović
- Cited by
- Internal MedicineHematologyNeurology
- Journals
- Journal of Clinical Oncology (8 papers)British Journal of Haematology (7 papers)British Journal of Cancer (4 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
John Imeson
48 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Internal Medicine 339
- Hematology 778
- Neurology 979
- Pulmonary and Respiratory Medicine 1.9k
- Cardiology and Cardiovascular Medicine 999
Countries citing papers authored by John Imeson
This map shows the geographic impact of John Imeson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Imeson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Imeson more than expected).
Fields of papers citing papers by John Imeson
This network shows the impact of papers produced by John Imeson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Imeson. The network helps show where John Imeson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John Imeson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 252 | |
| 2 | 2006 | 111 | |
| 3 | 2003 | 4 | |
| 4 | 2002 | 6 | |
| 5 | 2002 | 107 | |
| 6 | 2000 | 123 | |
| 7 | 2000 | 90 | |
| 8 | 2000 | 51 | |
| 9 | 2000 | 53 | |
| 10 | Validation of pharmacologically-guided dosing of carboplatin in paediatric patients | 1998 | 2 |
| 11 | 1998 | 39 | |
| 12 | 1998 | 19 | |
| 13 | 1998 | 170 | |
| 14 | Improvement in survival for Ewing's sarcoma by substitution of Ifosfamide for Cyclophosphamide | 1993 | 6 |
| 15 | 1992 | 21 | |
| 16 | 1992 | 37 | |
| 17 | 1990 | 97 | |
| 18 | 1990 | 90 | |
| 19 | EFFECTS OF CHANGES IN SMOKING AND OTHER CHARACTERISTICS ON CLOTTING FACTORS AND THE RISK OF ISCHAEMIC HEART DISEASEbreakdown → | 1987 | 346 |
| 20 | 1980 | 40 |
About John Imeson
John Imeson is a scholar working on Internal Medicine, Neurology and Genetics, having authored 48 papers that have together received 5.1k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (11 papers), Renal and related cancers (7 papers), Childhood Cancer Survivors' Quality of Life (6 papers), Acute Lymphoblastic Leukemia research (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Blood properties and coagulation (5 papers), Glioma Diagnosis and Treatment (5 papers) and Renal cell carcinoma treatment (4 papers). The work is most often cited by research in Internal Medicine (339 citations), Hematology (778 citations) and Neurology (979 citations). John Imeson has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Yvonne Stirling, Andy Haines, T W Meade, T W Meade, Simon G. Thompson, George J. Miller, Ranjan Chakrabarti, W. R. S. North, M Brozović and Ian Lewis. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Haematology, British Journal of Cancer, European Journal of Cancer and Pediatric Blood & Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.